The present invention relates to new prolylendopeptidase inhibitors of general formula (I).
대표청구항▼
[ What is claimed is:] [1.] A compound of formula (I) EQU A--B--C--D--L (I)wherein:A is formula (I), [ STR 196 ]wherein:R.sup.1, R.sup.2, R.sup.3 and R.sup.4 each is a hydrogen atom, halogen atom, hydroxyl group, straight chain or branched chain alkyl or alkenyl- or alkinyl or alkoxy- or alkenyloxy-
[ What is claimed is:] [1.] A compound of formula (I) EQU A--B--C--D--L (I)wherein:A is formula (I), [ STR 196 ]wherein:R.sup.1, R.sup.2, R.sup.3 and R.sup.4 each is a hydrogen atom, halogen atom, hydroxyl group, straight chain or branched chain alkyl or alkenyl- or alkinyl or alkoxy- or alkenyloxy- or alkinyloxy group consisting of 1-6 carbon atoms, nitro-group, amino group, monoalkylamino or monoacylamino group of 1-12 carbon atoms, or dialkylamino- or diacylamino group of 2-24 carbon atoms, where the acyl group is an alkyl, aralkyl, cycloalkyl or aryl type-, cyano group, mercapto group, carboxyl group, esterified carboxyl group of 2-7 carbon atoms, hydroxyalkyl group of 1-6 carbon atoms, acyl group of 1-7 carbon atoms, acyloxy group of 1-7 carbon atoms, phenyl or benzyl group, anilino group, benzoyl group, phenoxy group, benzyloxy group, isocyanato group, isothiocyanato group, alkylthio group of 1-6 carbon atoms, sulfamino or sulfamoyl group, thiocyanato or cyanato group;R and R.sup.6 each is a hydrogen atom, hydroxyl group, phenyl group or alkyl group of 1-4 carbon atoms or R.sup.5 and R.sup.6 together is an oxo group;B is a --(CH.sub.2).sub.m --C(.dbd.O)-- group, wherein m is an integer of 1 to 21; --O--(CH.sub.2).sub.p --C(.dbd.O)-- group wherein p is an integer of 1 to 3; or a [ STR 197 ]and R.sup.14 each is a hydrogen alkyl or alkoxy group of 1-6 carbon atoms, halogen, amino group optionally substituted with one or two alkyl groups of 1-6 carbon atoms, orphenyl, phenoxy, aryl-alkyl group of 7-12 carbon atoms or aryl-alkoxy group of 7-12 carbon atoms, each of them optionally are 1, 2 or 3 same or different substituents identical to R.sup.1, R.sup.2, R.sup.3 or R.sup.4 ; ortwo of R.sup.9, R.sup.10, R.sup.11, R.sup.12, R.sup.13 and R.sup.14 together is an oxo or epoxy group or further chemical bond or four of them together have two further chemical bonds and the remaining groups are hydrogen atoms; orR.sup.9, R.sup.10, R.sup.11, R.sup.12, R.sup.13 and R.sup.14 together with the chain carbon atoms is a saturated or unsaturated homocycle of 3-8 carbon atoms or a saturated or unsaturated heterocycle of 2-7 carbon atoms and a nitrogen or sulfur or oxygen atom, to which optionally an aromatic ring of 6-10 carbon atoms is condensed; andw is zero or 1;C is a prolyl group of formula (37), (39), or (40), [ STR 198 ]wherein:Hlg is a fluorine, chlorine, bromine, or iodine atom;R.sup.5 and R.sup.6 are, independently from each other, a hydrogen atom, hydroxyl group, phenyl group or alkyl group of 1-4 carbon atoms; orR.sup.5 and R.sup.6 together are an oxo-group;R.sup.16 is an alkoxy group of 1-4 carbon atoms, or an --NH--CH.sub.2 --CN group, or an --NH--CH.sub.2 --CO.sub.2 R.sup.7 group, where R.sup.7 is defined as above; or a D structural unit or an L structural unit; or a group of the formula (44), [ STR 199 ]wherein:R.sup.15 is a hydrogen atom, alkyl group of 1-6 carbon atoms, phenyl or naphthyl group;D is a covalent chemical bond; andL is a pyrrolidino or 2-cyanopyrrolidino group wherein the pyrrolidino or 2-cyanopyrolidino group is optionally substituted by one halogen atom or geminally by two halogen atoms;and optical, cis-trans, geometric isomers, epimers, tautomers or salts thereof.
Stillman, Suzanne Jaffe, Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s).
※ AI-Helper는 부적절한 답변을 할 수 있습니다.